Characterization of Ocular Biomaterial Uptake & Release
眼部生物材料吸收的表征
基本信息
- 批准号:RGPIN-2016-03887
- 负责人:
- 金额:$ 2.04万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2016
- 资助国家:加拿大
- 起止时间:2016-01-01 至 2017-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Biomaterials are materials that come into close contact with living biological cells or fluids. Some of the best examples of biomaterials include heart valves, blood vessels, artificial joint replacements, breast implants, intraocular lens implants (for use following cataract surgery), and contact lenses, of which the latter two are among the most widely used. Over 140 million people worldwide wear contact lenses, of which 90% use soft, hydrogel lenses, which are typically replaced after being used for 1 day to 1 month. In Canada alone, the 3 million wearers of lenses use approximately 30 million new soft lenses annually. These materials come into direct contact with the tear film on the surface of the eye, which is a highly complex fluid containing a wide variety of proteins, oils, metabolites and electrolytes. Once exposed to the tear film, these contact lens materials take up various components from it, some of which may induce inflammatory responses. Once removed, reusable lenses are placed in contact lens solutions that are also complex in their chemistry. These chemicals can be soaked up by the lens and released onto the eye when next inserted. Some of these chemicals can be damaging to the eye and induce low-grade inflammatory responses. Finally, bacteria from the fingers, soaking case or eye itself can also be taken up by the lens.
This grant will continue my work in developing an enhanced understanding of the interactions that occur between soft lens materials and the tear film, contact lens solutions and bacteria. It will use a wide variety of cutting-edge laboratory techniques, with a specific emphasis of trying to better understand contact lens-induced inflammation. Our latest work would suggest that certain tear film proteins are “protective” and are able to reduce bacterial contamination of the lenses. Other recent studies have shown that certain proteins change in configuration when exposed to lens materials and this new “form” may induce an inflammatory response. Thus, it may transpire that contact lens materials should be developed that encourage the deposition of certain tear film components and discourage others. This work will include examination of both commercial materials and also include “model” materials that we will fabricate internally that are not yet commercialised, to provide basic information on the ways that soft materials can be developed that exhibit improved performance.
Obtaining a greater understanding of the interactions that occur between contact lens materials, solutions and bacteria will help with the development of next generation contact lens materials and other ocular biomaterials. The results will provide excellent training for Canadian students in an area that provides great potential for employment, and will lead to better contact lens materials for the 3 million Canadians who wear contacts.
生物材料是与活的生物细胞或液体密切接触的材料。生物材料的一些最好的例子包括心脏瓣膜、血管、人工关节置换、乳房植入物、眼内透镜植入物(用于白内障手术后)和隐形眼镜,其中后两种是最广泛使用的。全球有超过1.4亿人佩戴隐形眼镜,其中90%使用软性水凝胶镜片,通常在使用1天至1个月后更换。仅在加拿大,300万镜片配戴者每年使用约3000万新的软性镜片。这些物质与眼睛表面的泪膜直接接触,泪膜是一种高度复杂的液体,含有各种蛋白质、油、代谢物和电解质。一旦暴露于泪膜,这些接触透镜材料从泪膜中吸收各种成分,其中一些可能诱发炎症反应。一旦取出,可重复使用的镜片被放置在接触透镜溶液中,接触镜片溶液的化学性质也很复杂。这些化学物质会被透镜吸收,并在下一次插入时释放到眼睛上。这些化学物质中的一些可能会损害眼睛,并引起低度炎症反应。最后,来自手指、浸泡盒或眼睛本身的细菌也可以被透镜吸收。
这项资助将继续我的工作,以提高对软透镜材料与泪膜、接触透镜溶液和细菌之间相互作用的理解。它将使用各种各样的尖端实验室技术,特别强调试图更好地了解隐形眼镜引起的炎症。我们的最新研究表明,某些泪膜蛋白具有“保护性”,能够减少镜片的细菌污染。其他最近的研究表明,当暴露于透镜材料时,某些蛋白质的构型发生变化,这种新的“形式”可能诱导炎症反应。因此,可能发生的是,应当开发促进某些泪膜组分的沉积并阻止其它组分的接触透镜材料。这项工作将包括对商业材料的检查,也包括我们将在内部制造的尚未商业化的“模型”材料,以提供有关软材料开发方法的基本信息,这些材料可以表现出更好的性能。
深入了解接触透镜材料、溶液和细菌之间的相互作用将有助于开发下一代接触透镜材料和其他眼部生物材料。研究结果将为加拿大学生提供一个就业潜力巨大的领域的优秀培训,并将为300万戴隐形眼镜的加拿大人带来更好的隐形透镜材料。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jones, Lyndon其他文献
Variability of the analysis of the tear meniscus height by optical coherence tomography
- DOI:
10.1097/opx.0b013e3181560ba8 - 发表时间:
2007-09-01 - 期刊:
- 影响因子:1.4
- 作者:
Bitton, Etty;Keech, Adam;Jones, Lyndon - 通讯作者:
Jones, Lyndon
CLEAR-Contact lens wettability, cleaning, disinfection and interactions with tears
- DOI:
10.1016/j.clae.2021.02.004 - 发表时间:
2021-03-25 - 期刊:
- 影响因子:3.2
- 作者:
Willcox, Mark;Keir, Nancy;Jones, Lyndon - 通讯作者:
Jones, Lyndon
In Vitro and In Vivo Evaluation of Novel Ciprofloxacin-Releasing Silicone Hydrogel Contact Lenses
- DOI:
10.1167/iovs.14-14855 - 发表时间:
2014-08-01 - 期刊:
- 影响因子:4.4
- 作者:
Hui, Alex;Willcox, Mark;Jones, Lyndon - 通讯作者:
Jones, Lyndon
Lipid deposition on contact lenses in symptomatic and asymptomatic contact lens wearers
- DOI:
10.1016/j.clae.2020.05.006 - 发表时间:
2021-01-05 - 期刊:
- 影响因子:3.2
- 作者:
Omali, Negar Babaei;Subbaraman, Lakshman. N.;Jones, Lyndon - 通讯作者:
Jones, Lyndon
Development of Mucoadhesive Drug Delivery System Using Phenylboronic Acid Functionalized Poly(D,L-lactide)-b-Dextran Nanoparticles
- DOI:
10.1002/mabi.201200216 - 发表时间:
2012-12-01 - 期刊:
- 影响因子:4.6
- 作者:
Liu, Shengyan;Jones, Lyndon;Gu, Frank X. - 通讯作者:
Gu, Frank X.
Jones, Lyndon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jones, Lyndon', 18)}}的其他基金
Biomaterials to Reduce Ocular Surface Inflammatory Response
减少眼表炎症反应的生物材料
- 批准号:
RGPIN-2017-03795 - 财政年份:2021
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
Biomaterials to Reduce Ocular Surface Inflammatory Response
减少眼表炎症反应的生物材料
- 批准号:
RGPIN-2017-03795 - 财政年份:2020
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
Biomaterials to Reduce Ocular Surface Inflammatory Response
减少眼表炎症反应的生物材料
- 批准号:
RGPIN-2017-03795 - 财政年份:2019
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
Biomaterials to Reduce Ocular Surface Inflammatory Response
减少眼表炎症反应的生物材料
- 批准号:
RGPIN-2017-03795 - 财政年份:2018
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
Biomaterials to Reduce Ocular Surface Inflammatory Response
减少眼表炎症反应的生物材料
- 批准号:
RGPIN-2017-03795 - 财政年份:2017
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
Cytation Cell Imaging Multi-Mode Reader
Cytation 细胞成像多模式读取器
- 批准号:
RTI-2017-00133 - 财政年份:2016
- 资助金额:
$ 2.04万 - 项目类别:
Research Tools and Instruments
Multiplexed Immunoassay Platform to Quantify Cytokines in Biological Samples
用于量化生物样品中细胞因子的多重免疫分析平台
- 批准号:
472311-2015 - 财政年份:2014
- 资助金额:
$ 2.04万 - 项目类别:
Research Tools and Instruments - Category 1 (<$150,000)
Characterization of hydrogel biomaterials and their interaction with components of the human tear film
水凝胶生物材料的表征及其与人泪膜成分的相互作用
- 批准号:
227593-2010 - 财政年份:2014
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
Characterization of hydrogel biomaterials and their interaction with components of the human tear film
水凝胶生物材料的表征及其与人泪膜成分的相互作用
- 批准号:
227593-2010 - 财政年份:2013
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
Effects of a low humidity environment and visual tasking on tear film protein composition
低湿度环境和视觉任务对泪膜蛋白质组成的影响
- 批准号:
445977-2012 - 财政年份:2012
- 资助金额:
$ 2.04万 - 项目类别:
Engage Grants Program
相似海外基金
Click2PrintAE®, an end-to-end digital workflow for 3D printed ocular prosthetics
Click2PrintAE®,3D 打印义眼的端到端数字工作流程
- 批准号:
10071306 - 财政年份:2023
- 资助金额:
$ 2.04万 - 项目类别:
Collaborative R&D
Impact of Oral Disulfiram on Aldehyde Dehydrogenase (ALDH) Mediated Ocular Fibrosis in Mucous Membrane Pemphigoid (OcMMP)
口服双硫仑对醛脱氢酶 (ALDH) 介导的粘膜类天疱疮 (OcMMP) 眼部纤维化的影响
- 批准号:
MR/X019195/1 - 财政年份:2023
- 资助金额:
$ 2.04万 - 项目类别:
Research Grant
Novel Polymer-antibody Conjugates as Long-acting Therapeutics for Ocular Diseases
新型聚合物-抗体缀合物作为眼部疾病的长效治疗药物
- 批准号:
10760186 - 财政年份:2023
- 资助金额:
$ 2.04万 - 项目类别:
Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain
识别治疗慢性术后眼痛的自体血清泪液的多模式生物标志物
- 批准号:
10794761 - 财政年份:2023
- 资助金额:
$ 2.04万 - 项目类别:
Effects of corneal sensory nerves, ocular surface temperature and blood flow on discomfort in contact lens wearers
角膜感觉神经、眼表温度和血流对隐形眼镜佩戴者不适的影响
- 批准号:
23K16828 - 财政年份:2023
- 资助金额:
$ 2.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Design and Development of selfpowered intelligent contact lens with 2D-MOS2 for Ocular Diagnostic
用于眼部诊断的2D-MOS2自供电智能隐形眼镜的设计与开发
- 批准号:
22KF0342 - 财政年份:2023
- 资助金额:
$ 2.04万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Tissue Hypoxia and Topical Oxygen Therapy in Ocular Mustard Gas Injury
眼芥子气损伤的组织缺氧和局部氧疗
- 批准号:
10630652 - 财政年份:2023
- 资助金额:
$ 2.04万 - 项目类别:
Developmental Contributions to the Functional Maturation of the Vestibulo-Ocular Reflex
前庭眼反射功能成熟的发育贡献
- 批准号:
10679875 - 财政年份:2023
- 资助金额:
$ 2.04万 - 项目类别: